MedTrace Logo

Prospective Cohort Study of Complications and Outcomes in Cirrhosis

NCT06374511 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 660

Last updated 2024-04-18

No results posted yet for this study

Summary

This is a multi-center, nested cohort study intended to investigate the prevalence, risk factors, and outcomes of complications in patients with acutely decompensated cirrhosis, especially focused on Cytomegalovirus (CMV) reactivation, bacterial infections, hepatic encephalopathy, and Hepatorenal syndrome. Patients diagnosed with acutely decompensated cirrhosis were enrolled. Upon enrollment, detailed baseline data were collected and samples were harvested. Complications were assessed during hospitalization. Post-discharge follow-up was conducted through telephonic interviews at Day 30 and Day 90.

Conditions

  • Decompensated Cirrhosis
  • CMV Reactivation
  • Overt Hepatic Encephalopathy

Interventions

DIAGNOSTIC_TEST

Test for CMV reactivation

All enrolled patients are monitored for CMV reactivation and hepatic encephalopathy using regular clinical tests or library test

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-04-04
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06374511 on ClinicalTrials.gov